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We have previously shown that voluntary running acts as an anxiolytic and ameliorates deficits in hippocampal 
neurogenesis and spatial learning. It also reduces depression-like behaviors that are normally observed in rats 
that were administered either low (30 mg/kg) or moderate (40 mg/kg) doses of corticosterone (CORT). However, 
the protective effects of running were absent in rats treated with a high (50 mg/kg) dose of CORT. We examined 
whether allowing animals to exercise for 2 weeks prior and/or concurrently with the administration of 50 mg/kg 
CORT treatment could have similar protective effects. We examined hippocampal neurogenesis using immuno-
histochemical staining of proliferative and survival cells with the thymidine analogs (BrdU, CIdU, and IdU). In 
addition, we monitored synaptic protein expression and quantified the levels of neurotrophic factors in these ani-
mals as well as performing behavioral analyses (forced swim test and sucrose preference test). Our results indicate 
that the depressive phenotype and reductions in neurogenesis that normally accompany high CORT administration 
could only be prevented by allowing animals to exercise both prior to and concurrently with the CORT administra-
tion period. These animals also showed increases in both synaptophysin and PSD-95 protein levels, but surprisingly, 
neither brain-derived neurotrophic factor (BDNF) nor insulin-like growth factor 1 (IGF-1) levels were increased 
in these animals. The results suggest that persistent exercise can strengthen resilience to stress by promoting 
 hippocampal neurogenesis and increasing synaptic protein levels, thereby reducing the deleterious effects of stress.
Key words: Hippocampal neurogenesis; Depression-like behavior; Synaptic plasticity; Physical exercise; 
Brain-derived neurotrophic factor; Insulin-like growth factor
INTRODUCTION
It has recently been shown that hippocampal neuro-
genesis plays a significant role in regulating animal stress 
responses and depressive behaviors (40). Indeed, it has 
even been postulated that a decrease in neurogenesis may 
precipitate the onset of depression (21), although a sus-
tained elevation of glucocorticoids with chronic stress can 
also severely impair hippocampal neurogenesis, synaptic 
plasticity, and increase depressive behaviors (28,37,45). 
Repeated injection of the major stress hormone corti-
costerone (CORT) in rodents provides a reliable animal 
model for studying stress-triggered depressive disorders 
(20). The behavioral changes exhibited by these ani-
mals are fairly similar to that of clinical patients, and the 
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severity of induced behavioral depression parallels the 
magnitude of the dose of CORT administered (23,49). 
Our prior work has shown that voluntary wheel running 
for 2 weeks can decrease the incidence of depression-like 
behavior in the rats treated with 30 or 40 mg/kg, but not 
50 mg/kg of CORT (49). In addition, voluntary exercise 
rescued hippocampal neurogenesis in these animals and 
elevated brain-derived neurotrophic factor (BDNF) lev-
els, indicating some possible mechanisms for the thera-
peutic effects of exercise in this model.
Although the mechanisms underlying exercise-mediated 
antidepressant effects have yet to be fully elucidated, increas-
ing hippocampal neurogenesis is associated with a decrease 
in depressive behaviors (7,42). Interestingly, exercise has 
also been shown to increase levels of neurotrophic factors 
like BDNF and insulin-like growth factor 1 (IGF-1) that 
are important for neuronal survival (5,19,25). Wheel run-
ning for 1 week prior to forced swim-induced stress inhib-
its the downregulation of hippocampal BDNF mRNA as 
well as prolongs swimming time (1). In addition, com-
bining antidepressant treatments with running can have 
synergistic effects and increase BDNF mRNA levels more 
than either alone (35). We hypothesized that prior physical 
conditioning might also protect the brain from subsequent 
stress by creating a prolonged increase in neurotrophic 
factor levels and enhanced neurogenesis.
To examine this hypothesis, we examined 1) whether 
2 weeks of prior running could reduce the behavioral 
deficits that are produced by 50 mg/kg CORT treatment; 
2) whether these behavioral changes are associated with 
altered hippocampal neurogenesis and synaptic plastic-
ity; and 3) whether there are corresponding changes in 
hippocampal and serum levels of BDNF and IGF-1. 
MATERIALS AND METHODS
Animals and Housing Conditions
The experimental procedures were approved by the 
Committee on the Use of Live Animals in Teaching and 
Research at the University of Hong Kong. Adult male 
Sprague–Dawley rats (250 ± 20 g) were purchased from 
the laboratory animal unit of the University of Hong 
Kong and were housed individually in the cage with a 
locked wheel or unlocked wheel. All animals were kept 
on a 12-h light–dark cycle with ad libitum access to food 
and water. In this study, animals (n = 4–6/group) were 
divided into four groups: 1) Control rats without run-
ning (CON); 2) CORT-treated rats that were allowed to 
run only during the 2-week CORT administration period 
(CR); 3) CORT-treated rats with the 2-week prior running 
only (PR); 4) CORT-treated rats that were allowed to run 
both prior and concurrently with the CORT administration 
period (PR + CR). The timeline of treatments and animal 
grouping are illustrated in Figure 1. We have previously 
documented that nonrunning rats receiving CORT (NR) 
treatment showed a significant decrease in hippocampal 
cell proliferation along with increased depressive behav-
ior (49), whereas vehicle-treated running rats (R + Vel) 
showed significant increase in hippocampal neurogenesis 
and decrease in depressive behavior (49). For a ready 
comparison, the corresponding data of NR and R + Vel 
groups was derived from our previous publications 
(49,50) and were included in figures as specified.
Rats were treated with sesame oil (Sigma-Aldrich, St 
Louis, MO, USA) or CORT (50 mg/kg, Sigma-Aldrich) 
for 2 weeks. The doses of 5-iodo-2¢-deoxyuridine (IdU, 
Sigma-Aldrich; 57.7 mg/kg body weight) and 5-chloro-
2¢-deoxyuridine (CIdU, Sigma-Aldrich; 42.5 mg/kg body 
weight) were applied to label different populations of 
proliferating cells (17). IdU prepared in 0.9% saline solu-
tion (Sigma-Aldrich) containing 0.01% NaOH (Sigma-
Aldrich) was injected intraperitoneally during the last 
3 days of the prior running stage to study the survival of 
cells born before CORT injection, while CIdU (prepared 
in 0.9% NaCl solution) was administered during the last 
3 days of CORT treatment to study cell proliferation. 
Bromodeoxyuridine (BrdU, Sigma-Aldrich; 50 mg/kg 
body weight) was dissolved in 0.9% saline and adminis-
tered intraperitoneally prior to initiation of prior running.
Administration of CORT
The stock solution of CORT at the dose of 50 mg/kg 
and sesame oil were prepared and injected subcutane-
ously as described by Hellsten et al. (22). Subcutaneous 
injection of CORT in the neck region has been reported to 
increase blood levels of CORT over a period of 24 h (37). 
CORT was prepared as a stock by suspending CORT in 
sesame oil, followed by vortex and sonication. Injection 
was made daily at 4:00 p.m. continuously for 2 weeks. 
The control rats received daily injections of sesame oil.
Exercise Training
Runners were individually housed in cages with 
unlocked wheels (diameter, 31.8 cm; width, 10 cm; 
Nalgene Nunc International, Rochester, NY, USA), while 
nonrunners were housed in similar conditions but with 
locked wheels. The time points for locking and unlocking 
manipulations are indicated in Figure 1. Wheel revolu-
tions were recorded at 1-h intervals using the VitalViewer 
software (Mini Mitter Company, Inc., Bend, OR, USA). 
Forced Swim Test (FST)
Depression-like behavior was measured according to 
the method of Porsolt et al. (33). Briefly, animals were 
initially allowed to adapt to the testing room for 2 h in 
the afternoon (between 2:00 p.m. and 6:00 p.m.). The 
rats were then placed in a custom-made cylinder (pro-
duced by the workshop of Department of Physiology, the 
University of Hong Kong, Hong Kong, 60 cm height × 25 cm 
SUSTAINED RUNNING PREVENTS DEPRESSION 483
diameter) containing tap water for 15 min on day 1 and 
5 min on day 2. Behavioral performance in day 2 was 
videotaped, and the immobility time was scored with the 
experimenter blinded to the animal group identity.
Sucrose Preference Test (SPT)
The rats were simultaneously offered with 1% sucrose 
(Sigma-Aldrich) solution and tap water for 24 h. The posi-
tion of the two bottles was swapped after 12 h. The bottles 
were weighed before and after the test to calculate the con-
sumption of water and sucrose solution. The sucrose pref-
erence was presented as the percentage of sucrose solution 
to the total amount of liquid consumption. Decrease in 
sucrose preference indicates the state of anhedonia-like 
behavior that is frequently seen in depressive patients.
Tissue Preparation
Animals were euthanized by overdose of pentobarbi-
tone (Alfasan International B.V. Woerden, Holland) and 
perfused transcardially with 0.9% NaCl (Sigma-Aldrich), 
followed by 4% paraformaldehyde (International Labo-
ratory, San Francisco, CA, USA). The brain was post-
fixed at 4°C overnight and then left in 30% sucrose buffer 
until it sank. Coronal sections of 40-µm thickness were 
cut through the hippocampus from the bregma −3.30 mm 
to −4.52 mm (32). 
Immunohistochemistry
Brain sections were bathed in 0.01 M citric acid (USB 
Corporation, Cleveland, OH, USA) (pH = 6.0) at 95°C 
for 30 min in a water bath. After three 0.01 M phosphate-
 buffered saline (PBS; Sigma-Aldrich) rinses, sections 
were then incubated in 2 N HCl (Sigma-Aldrich) for 
30 min at 37°C, followed by 15-min incubation in boric 
acid buffer (Merck KGaA, Darmstadt, Germany) at room 
temperature. After thorough rinses in 0.01 M PBS, sec-
tions were incubated overnight with mouse anti-BrdU 
antibody (1:1,000; Roche Molecular Biochemicals, Essex, 
UK, for detecting IdU and BrdU) or rat anti-BrdU (1:1,000; 
Abcam, Cambridge, MA, USA, for detecting CIdU) in 
antibody diluents at room temperature. Sections were 
washed and incubated with biotinylated goat anti-mouse 
or anti-rat antibody (1:200; Vector Laboratories, Inc., 
Burlingame, CA, USA). Finally, sections were incubated 
with an avidin–biotin complex (Vector Laboratories), and 
the IdU/CIdU/BrdU immunoreactivity was visualized 
with liquid diamino benzidine substrate kit (Invitrogen, 
Carlsbad, CA, USA). Brain sections were counted in a 
1-in-12 series of coronal sections.
For double staining of CIdU and doublecortin (DCX: 
immature neuronal marker), the sections were concurrently 
incubated with rat anti-BrdU antibody (1:1,000, Abcam) 
and rabbit anti-DCX (1:100, Abcam) overnight at room 
Figure 1. The treatment timeline. The rats were allowed to adapt to a new living environment with a locked wheel in the cage for 
2 days. The wheels were then unlocked for the rats with running for 14 days prior to the 50 mg/kg corticosterone (CORT) treatment. 
5-Iodo-2¢-deoxyuridine (IdU) was injected to study cell survival, while 5-chloro-2¢-deoxyuridine (CIdU) was injected to examine 
cell proliferation, followed by forced swim test (FST) 24 h later. Rats injected with bromodeoxyuridine (BrdU) were sacrificed 24 h 
after sucrose preference test. The animals were divided into four groups: 1) Control without running (CON); 2) CORT-treated runners 
that were allowed to exercise during the CORT administration period only (CR); 3) CORT-treated rats with prior running only (PR); 
4) CORT-treated rats that were allowed to exercise both prior and concurrently with the CORT administration period (PR + CR).
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temperature. Thereafter, they were probed with Alexa 
fluor 488-conjugated goat anti-rabbit and 568-conjugated 
goat anti-rat (1:200, Molecular Probes, Eugene, OR, 
USA) for 2 h at room temper ature. After rinsing, sections 
were coverslipped with the mounting medium (Dako, 
Carpinteria, CA, USA) for later analysis.
Quantification of Cell Proliferation, Neuronal 
Differentiation, and Cell Survival
Six coronal brain sections containing IdU or CIdU-
positive cells per animal were counted through a 40× 
objective using the Stereo Investigator (MicroBrightField, 
Williston, VT, USA) as previously performed (49,52). The 
number of positive cells was counted within the granular 
cell layer (GCL) and two cell diameters below the GCL, 
ignoring those cells in the uppermost focal plane. The esti-
mated cell count was multiplied by 12 to obtain the esti-
mated total number of IdU-, CIdU-, or BrdU-positive cells. 
The cell counting was performed in a sample-blind manner.
For immunophenotypic analysis, 30 CIdU-positive cells 
per animal were randomly selected and their coexpres-
sion of CIdU and DCX analyzed in a blinded manner by 
fluorescence microscopy (Axioplan, Zeiss, Oberkochen, 
Germany) with 40× magnification. Double staining was 
defined by CIdU-positive nucleus stained together with 
DCX-positive surrounding soma in a cell. The proportion 
of DCX-positive cells over the 30 CIdU-positive cells 
was used as the indicator for neuronal differentiation as 
previously performed (50).
Protein Extraction and Western Blot Analysis
Total proteins were extracted from freshly isolated 
hippocampi after euthanizing rats. Tissues were lysed 
with radioimmunoprecipitation assay (RIPA) buffer (Cell 
Signaling Technology, Danvers, MA, USA) supplemented 
with the protease and phosphatase inhibitor cocktails and 
phenylmethanesulfonyl fluoride (Sigma-Aldrich). Samples 
were homogenized and subsequently sonicated (Branson 
Sonicator #2510, Branson Ultrasonics, Danbury, CT, 
USA) for 20 s with a 50% pulse and cleared by centrifu-
gation (10,000 × g) at 4°C for 30 min. Supernatant protein 
was collected and stored at −80°C until use. Supernatant 
protein concentrations were determined by the DC Pro-
tein assay (Bio-Rad Laboratories, Hercules, CA, USA). 
Homo genate containing 20 µg of protein per lane was 
separated by sodium dodecyl sulfate-polyacrylamide gel 
electro phoresis (SDS-PAGE) (Bio-Rad Laboratories) and 
trans ferred to polyvinyldifluoride (PVDF) membranes 
(Bio-Rad Laboratories). Nonspecific binding was blocked 
with 5% bovine serum albumin (Sigma-Aldrich) for 
1 h. Blots were then probed overnight at 4°C with pri-
mary antibodies, followed by 1-h incubation with sec-
ondary antibodies conjugated to horseradish peroxidase 
(HRP) and then developed by chemiluminescence detec-
tion (Luminate Forte; Millipore, Ballerica, MA, USA). 
The antibodies used for detection were mouse anti-b-
 actin (1:7,000; Dako, Glostrup, Denmark), rabbit anti-
synaptophysin (1:3,000), and rabbit anti-postsynaptic 
density 95 (PSD-95; 1:3,000; Cell Signaling Technol-
ogy); and goat anti-mouse and goat anti-rabbit IgG-HRP 
(1:5,000, Dako).
Measurement of Serum and Hippocampal 
BDNF and IGF-l
Animals were anesthetized using the mixture of keta-
mine and xylazine (2:1 ratio), and blood was collected 
from the tail vein within 3 min using a 25-gauge nee-
dle. Blood samples were placed at room temperature for 
30 min, followed by centrifugation (Eppendorf centrifuge 
5417R, Hauppauge, NY, USA) at 1000 × g for 20 min at 
4°C. Serum aliquots were then stored at −80°C until use. 
The BDNF and IGF-1 levels were determined using com-
mercially available ELISA kits (BDNF: Chemikine BDNF 
Sandwich ELISA Kit, Millipore; Mouse/Rat IGF-1 
Quantikine ELISA Kit, R & D System, Minneapolis, 
MN, USA). Sample neurotrophin levels were calculated 
from the standard curve transforming the absorbance into 
neurotrophin concentrations.
BDNF Enzyme-Linked Immunosorbent Assay 
In brief, BDNF standards, 100-µl serum samples in 
200-fold dilution and 50-µg hippocampal protein sample 
brought to 100 µl using sample diluent were added to a 
96-well plate and incubated overnight with shaking at 
4°C. After three washes of the plate with wash buffer, 
the diluted biotinylated mouse anti-BDNF monoclonal 
antibody was added to the plate and then incubated at 
room temperature for 3 h. After washing, the diluted 
streptavidin–HRP conjugate solution was added and incu-
bated for 1 h at room temperature. After 15-min incuba-
tion with TMB/E substrate, the reaction was stopped by 
adding stop solution. The absorbance was then measured 
at 450 nm.
IGF-1 Enzyme-Linked Immunosorbent Assay 
The IGF-1 standard, serum samples in 1,000-fold dilu-
tion and 50-µg protein that were brought to the same total 
volume of standard or serum samples by assay diluent 
were added to a 96-well plate and incubated with 150-µl 
assay diluent for 2 h at 4°C. After washes with wash buf-
fer, the plate was incubated with cold IGF-1 conjugate for 
1 h at 4°C, followed by washings and 30-min incubation 
with substrate solution at room temperature. The reaction 
was stopped by adding stop solution, and absorbance was 
measured at 450 nm and corrected by subtracting reading 
at 570 nm.
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Statistical Analysis
ANOVA analysis with Fisher’s post hoc test was applied 
for all data sets. Values are presented as mean ± SEM.
RESULTS
Sustained Running Decreased Depression-Like 
Phenotype in Rats Treated With 50 mg/kg CORT
We have previously shown that 50 mg/kg CORT treat-
ment in nonrunners (NR) significantly increased immo-
bility time in the forced swim test (49,52). Here we 
observed significant increases in immobility time in the 
CR and PR groups when compared to the CON group 
[F(3, 18) = 7.366, p < 0.005] (Fig. 2A), indicating both 
concurrent running alone and prior running alone could 
not alleviate CORT-induced depressive behavior. In con-
trast, continuous running effectively ameliorated such a 
depressive behavior, as indicated by no significant differ-
ence in immobility time between the CON and PR + CR 
group. Interestingly, rats with prior running showed sig-
nificantly less immobility time when compared to rats 
with concurrent running (p < 0.05), suggesting prior run-
ning alone somehow could reduce depression level to 
a greater extent when compared to concurrent running 
alone, though none of them were effective enough to alle-
viate CORT-induced depressive behavior.
Anhedonia-like behavior, a core symptom of depres-
sive patients, was measured by the sucrose preference test. 
Similarly, continuous running reversed CORT-suppressed 
sucrose consumption (p > 0.05 compared to the control, and 
p < 0.05 compared to the CR group) (Fig. 2B). Prior run-
ning only or concurrent running only failed to attenuate 
CORT-suppressed sucrose consumption (p < 0.05 compared 
to the control). The behavioral data suggest that continuous 
running, but not prior running or concurrent running, could 
effectively alleviate the depression-like phenotype in rats 
treated with high dose of CORT.
Continuous Running Ameliorated Decrease in 
Hippocampal Neurogenesis and Increased Cell 
Survival in CORT-Treated Rats 
We next examined whether continuous running exerts 
its therapeutic effect via restoring hippocampal neuro-
genesis in the CORT-treated rats. ANOVA analysis on 
CIdU-labeled cells revealed that continuous running 
restored the decrease in cell proliferation to the control 
level, whereas prior running or concurrent running alone 
was unable to reverse the decrease [F(3, 16) = 7.254, 
p < 0.005] (Fig. 3A). Decreases in cell proliferation were 
equivalent in the CR, PR, and NR groups (Fig. 3B).
We studied the survival of two different cell popula-
tions that were born in different periods. Cells labeled 
with IdU were used to estimate the survival of cells 
labeled during the last 3 days of running. The number of 
IdU-positive cells in rats with prior running or concur-
rent running was comparable to that of the control group 
(Fig. 3D). In contrast, the continuous running that the 
PR + CR group engaged in showed significantly increased 
cell survival (p < 0.05 CR vs. PR + CR group) (Fig. 3D). 
BrdU labeling was used to examine the survival of cells 
born before the initiation of prior running. There was no 
significant difference in number of BrdU-labeled cells 
[F(3, 19) = 0.865, p = 0.479] (Fig. 3E), suggesting that the 
survival of this cell population was not affected by the treat-
ments. Interestingly, we observed a significant negative 
 correlation between the number of IdU-positive cells and 
Figure 2. Continuous running decreased depression-like phenotypes. (A) Immobility time was increased in the CR and PR groups 
compared to the CON group, while there is no significant difference between the CON and PR + CR groups. The PR and PR + CR 
groups showed that significantly less time was spent in immobility compared to the CR group. **p < 0.005, *p < 0.05 compared to 
the control group, #p < 0.05 compared to the CR group. (B) Sucrose consumption was significantly decreased in CR and PR groups, 
whereas the PR + CR group showed equivalent sucrose consumption to the CON group. The PR + CR group showed significant higher 
sucrose consumption compared to the CR group. The data indicated that prior running together with concurrent running is required to 
ameliorate anhedonia-like behavior in rats treated with 50 mg/kg CORT. *p < 0.05, **p < 0.005 compared to the CON group, #p < 0.05 
compared to the CR group.
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time spent in immobility (R2 = 0.275, p = 0.031) (Fig. 3F), 
suggesting possible involvement of this population of 
cells in the depressive behavior phenotype in the CORT-
treated rats.
Previous data revealed that 50 mg/kg CORT treat-
ment  significantly decreased neuronal differentiation in 
nonrunners (52). There was a significant increase in the 
number of cells colabeled with CIdU and the immature 
neuronal marker DCX in the CR and PR + CR groups 
[F(3, 22) = 4.584, p < 0.05] (Fig. 4). We subsequently esti-
mated the total number of newborn neurons by multiplying 
the number of proliferating cells (CIdU-positive cells) to 
the percentage of newborn cells differentiated into neuronal 
lineage (the ratio of CIdU-positive cells expressing DCX) 
(15). The results demonstrated that continuous running 
prevented the CORT-induced decrease in neurogenesis that 
was observed in the NR group in our previous study (52). 
Both the PR and the CR groups showed significant decreases 
in neurogenesis [F(3, 16) = 5.276, p < 0.05] (Table 1), 
 indicating that prior running together with concurrent run-
ning was required to ameliorate the effects of CORT.
Continuous Running and Prior Running Increased 
Synaptic Plasticity in CORT-Treated Rats
Running and stress are known to have opposite effects 
on hippocampal synaptic plasticity (31,43). To examine 
this issue, we assayed synaptic proteins that are impor-
tant for synaptic plasticity: synaptophysin and PSD-95 in 
the hippocampus. Western blot analysis revealed signifi-
cant changes in protein levels of synaptophysin (Fig. 5B) 
Figure 3. Continuous running ameliorated the decrease in hippocampal neurogenesis in the CORT-treated runners. (A) There was a 
significant decrease in CIdU-positive cells in the CR and PR groups when compared to the CON group. Conversely, the PR + CR group 
showed a comparable level of CIdU-positive cells to the control and a significant increase in CIdU positive cells compared to the CR 
group, indicating continuous running rescued hippocampal cell proliferation in CORT-treated runners. *p < 0.05 compared to the CON 
group; #p < 0.05 compared to the CR group. (B) Decreases in the number of proliferating cells were equivalent in nonrunning (NR), 
PR and CR groups, indicating an inability of prior running alone or concurrent alone in rescuing CORT-induced suppression in cell 
proliferation. Continuous running rescued this decrease as indicated by a significant difference between PR + CR and NR or CR or 
PR groups. *p < 0.05, #p < 0.05 compared to the other groups. R + Vel: running and vehicle treated. The data of NR and R + Vel groups 
were derived from our previous publications (49,50). (C) Representative images of CIdU-positive cells in the dentate gyrus. Scale 
bar: low magnification 50 µm; high magnification: 25 µm. (D) The CR group showed a lower trend in the number of surviving cells to 
the control group. Prior running significantly increased IdU-labeled cells in the PR + CR group compared to the CR group, indicating 
continuous running increased cell survival. *p < 0.05 compared to the PR + CR group. (E) There was no difference in BrdU-positive 
cells among the treatment groups. (F) The number of IdU-labeled cells was negatively correlated with the time spent in immobility. 
The rats with a higher number of IdU-labeled cells showed a lower degree of depression-like behavior in terms of less immobility time. 
The data were analyzed using Pearson correlation test (R2 = 0.275, p = 0.031).
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[F(3, 22) = 30.594, p < 0.0005] and PSD-95 [F(3, 22 = 
17.476, p < 0.0005] in the hippocampus.
Continuous running in the PR + CR group robustly 
increased both protein levels in comparison to the CON, 
CR, and PR groups (p < 0.05). Levels for both synapto-
physin and PSD-95 in the CR group were significantly 
decreased (p < 0.05 compared to the CON group), indicat-
ing that exercise during the CORT administration did not 
have protective effects for synaptic protein expression. 
Interestingly, prior running maintained protein levels of 
synaptophysin and significantly increased levels of PSD-95 
when compared to the control group (p < 0.05).
Hippocampal and Serum Levels of BDNF and IGF-1 
Were not Increased in All CORT-Treated Rats
The neurotrophins, such as IGF-1 and BDNF, are 
believed to play an important role in running-induced 
neurogenesis (11). We examined whether changes of hip-
pocampal and serum IGF-1 and BDNF levels correspond 
to changes of hippocampal neurogenesis. Hippocampal and 
serum levels of BDNF [Fig. 6A, hippocampus: F(3, 20) = 
10.062, p < 0.005; Fig. 6B, serum: F(3, 20) = 5.303, p < 0.05] 
and IGF-1 [Fig. 6C, hippocampus: F(3, 20 = 10.062, 
p < 0.005; Fig. 6D, serum: F(3, 23) = 8.927, p < 0.005] were 
decreased in both the PR and CR groups. Surprisingly, 
although the PR + CR rats showed elevated hippocampal 
neurogenesis, they also exhibited a significant decrease 
in both hippocampal and serum BDNF and IGF-1 levels 
(p < 0.05).
DISCUSSION
Regular exercise has been well documented to exert 
preventative or curative effects on depression (13,41); 
however, the underlying mechanism(s) are not fully clear 
at present. Our results showed that continuous running 
in the PR + CR group provided protection from the nega-
tive effects of CORT administration. Increase in depres-
sive phenotype and reductions in neurogenesis that are 
induced by high CORT administration could only be 
prevented in rats with continuous running. These animals 
also showed increases in both synaptophysin and PSD-95 
protein levels, but surprisingly, BDNF and IGF-1 levels 
were not increased in these animals. These results suggest 
that sustained physical exercise can protect against stress 
via rescuing hippocampal neurogenesis and increase syn-
aptic protein contents.
Figure 4. Running during 14-day CORT treatment increased neuronal differentiation. (A) Concurrent running during the administra-
tion of CORT treatment increased neuronal differentiation in CR and PR + CR groups when compared to the CON group. Prior running 
did not affect neuronal differentiation. (B) Representative image of colabeling of CIdU (in red) with doublecortin (in green). *p < 0.05 
compared to the control group. Scale bar: 50 µm.
Table 1. Total Number of Newborn Neurons and Surviving Cells
CIdU+ Cell
(Proliferating Cells)
DCX/CIdU Ratio
(Neuronal Differentiation)
Number of 
Newborn Neurons
IdU+ Cell 
(Survival Cells)
CON 9,744 ± 1,002 0.67 6,550 ± 777 7,080 ± 730
CR 5,124 ± 605* 0.81† 4,156 ± 491* 4,929 ± 678‡
PR 5,558 ± 357* 0.72 3,276 ± 761* 6,470 ± 1,400
PR + CR 7,770 ± 1118 0.81† 6,324 ± 910 9,705 ± 1,520
The number of newborn neurons was obtained by multiplying the total number of CIdU-labeled cells with the ratio of CIdU-labeled cells that expressed 
the neuronal marker DCX. Combining prior running (PR) and concurrent running (CR) restored the decrease in newborn neurons in the 50 mg/kg 
corticosterone (CORT)-treated rats. However, prior running alone was unable to restore CORT suppression of newborn neurons. *p < 0.05 compared 
to the control and PR + CR groups, respectively. †p < 0.05 compared to CON. ‡p < 0.05 compared to the PR + CR group. DCX: doublecortin; CIdU: 
5-chloro-2¢-deoxyuridine; IdU: 5-iodo-2¢-deoxyuridine.
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Figure 5. Continuous running increased synaptic protein expressions in CORT-treated rats. (A) Representative bands for Western blot 
analysis. (B) Significant increases in levels of both synaptophysin and postsynaptic density 95 (PSD 95) were found in the PR + CR 
group compared to the CON group. Conversely, concurrent running (CR) could not rescue the decrease in synaptophysin and PSD 95 
protein expression. Prior running alone maintained synaptophysin protein at the control levels and increased PSD 95 levels. *p < 0.005 
compared to the other three groups respectively; **p < 0.05; #p < 0.005 compared to the CON group. ACTB: b actin.
Figure 6. Decreased hippocampal and serum levels of BDNF and IGF in CORT-treated rats. (A) Hippocampal and (B) serum brain-
derived neurotrophic factor (BDNF) levels were significantly decreased following CORT treatment when compared to the control. 
(C) Hippocampal and (D) serum insulin-like growth factor-1 (IGF-1) levels were significantly decreased following CORT treatment. 
*p < 0.05, **p < 0.005 compared to the CON group.
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Continuous Running Reverses Depression-Like Behavior 
in Association With Enhanced Cell Proliferation, 
Neurogenesis, and Cell Survival
Physical exercise is known to increase cell proliferation, 
neuronal differentiation, and neuronal survival (44), while 
CORT showed opposite effects (48). With the approach 
of labeling proliferating cells at different time points, we 
measured these three indices concurrently. Our previous 
studies have shown that running enhances hippocampal 
cell proliferation in rats treated with 20 mg/kg CORT (51) 
and counteracts decrease in neurogenesis and depressive 
behavior induced by 30 and 40 mg/kg CORT treatment 
(49). A recent study indicated that running prior to induc-
tion of bacterial meningitis increased animal survival and 
hippocampal neurogenesis (46). We found that only con-
tinuous running counteracted high doses of CORT-induced 
decrease in hippocampal neurogenesis, while prior run-
ning or concurrent running alone could not rescue such 
decrease. The decrease in number of proliferating cells in 
CORT-treated rats with prior running or concurrent running 
alone was equivalent to that in CORT-treated rats without 
running. Reduction of newborn neurons in our rats is likely 
due to the decrease in proliferating cells, rather than differ-
entiation or survival, since colabeling of CIdU with DCX 
could be increased following concurrent running, and cell 
survival rate indicated by the number of IdU- and BrdU-
positive cells in rats with prior or concurrent running were 
comparable to the control group.
Fabel and colleagues observed running-induced increase 
in adult neurogenesis after 35 days of cessation of running, 
suggesting that running could prime a survival-promoting 
effect on newborn cells after cessation of running (15). 
Conversely, a high dose of CORT suppressed not only 
cell proliferation but also survival of newborn cells (47). 
Continuous running considerably increased IdU-positive 
numbers when compared to the concurrent running group, 
suggesting prior running together with concurrent run-
ning will be required for promoting neuronal survival. 
Hippocampal neurogenesis has been proposed to mediate 
the therapeutic effects of antidepressants (such as flu-
oxetine) (36) and physical exercise (7,38,42) in animal 
models of depression. The present study further supports 
this functional role of hippocampal neurogenesis as CORT-
treated animals with decreased hippocampal neurogenesis 
showed depression-like phenotypes, whereas CORT-treated 
rats with continuous running showed improvement in 
depressive-like phenotype along with enhanced hippo-
campal neurogenesis.
Synaptic Plasticity Is Required for Running-Elicited 
Antidepressant Effect in Stressed Rats
Our CORT-treated rats with prior running showed sig-
nificantly less time spent on immobility when compared 
to that with concurrent running, indicating that prior 
running potentially reduces the severity of depression-like 
behavior. A significant correlation between the number of 
IdU-positive cells and time spent on immobility (Fig. 3F) 
suggested that these surviving cells may be partially 
involved in depressive phenotype in the rats, as newborn 
neurons could be functionally integrated into preexisting 
circuitry before they become fully mature (29). The bene-
ficial effect of prior running may also partially be fulfilled 
by enhanced synaptic plasticity since prior running main-
tained synaptophysin protein levels and enhanced protein 
PSD-95 levels. PSD-95 is abundantly located at the post-
synaptic site to facilitate dendritic spine formation and 
stabilization (34,39). Overexpression of PSD-95 could 
increase spine formation and enhance synaptic connection 
with the presynaptic terminals (30). Decrease in both syn-
aptophysin and PSD-95 by CORT treatment accordingly 
may indicate the reduced synaptic contact and connection 
within the hippocampal circuit under stress. Concurrent 
running could not reverse a CORT-induced decrease in 
hippocampal neurogenesis and synaptic proteins, which 
may consequently lead to disrupted hippocampal function 
and subsequent behavioral deficits in CORT-treated rats. 
Prior running also failed to reduce depression-like pheno-
type in CORT-treated rats, which is likely due to decreased 
hippocampal neurogenesis, despite there being an increase 
in levels of synaptic protein PSD-95. Conversely, continu-
ous running showed its antidepressant effect together with 
restored hippocampal neurogenesis and increased synap-
tic proteins. These observations echo our previous finding 
and substantiate our hypothesis that both dendritic plastic-
ity and neurogenesis are required to maintain hippocam-
pal function under stress condition (49).
Continuous Running Improves Hippocampal Plasticity 
in the Presence of Decreased Neurotrophins
BDNF and IGF-1 have been recognized as the impor-
tant mediators for running-induced hippocampal neuro-
genesis, synaptic plasticity, and cognitive improvement 
(12). Benefits of preexposure to running or antidepres-
sant have been shown to prevent decrease in hippocam-
pal BDNF levels and increase in immobility time (1,35). 
BDNF has been reported to elevate after running for 28 
days in young mice (2), which remained at significantly 
high levels even 1–2 weeks after the cessation of exer-
cise (6). We expect to observe an increase in both BDNF 
and IGF-1 levels in the rats with continuous running. 
Interestingly, we found that continuous running amelio-
rated the CORT effect in concurrence with decreases in 
both hippocampal and serum levels of BDNF and IGF-1. 
Our previous study has suggested that mild changes of 
neurotrophins in the brain may not be reflected by changes 
in blood levels (50). The present study demonstrated a 
corresponding change in central and peripheral levels 
of neurotrophins, suggesting that significant changes of 
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neurotrophins in the brain could correspond to changes in 
the blood. However, the present study suggests that these 
changes may not necessarily correlate with changes in 
hippocampal plasticity.
To the best of our knowledge, this is the first report 
showing that increased neurogenesis and enhanced syn-
aptic plasticity could coexist with decrease in hippocam-
pal and serum levels of neurotrophic factors. BDNF levels 
are increased at week 4, then return to baseline at week 8 
in multiple sclerosis subjects (24). Most clinical studies 
have shown a transient increase in peripheral BDNF lev-
els following an acute aerobic exercise; however, there 
is no clinical study showing a long-lasting response of 
peripheral BDNF to physical training (10). Long-term 
physical exercise is known to improve cognitive func-
tion in normal subjects or subjects with dementia (3). 
However, decrease in serum BDNF (9) and IGF-1 levels 
(14) have been reported in normal subjects with chronic 
physical training. An inverse relationship between car-
diorespiratory fitness and serum BDNF levels has also 
been reported (16,41). The similar finding has been 
observed in our recent study showing a negative corre-
lation between neurotrophic factors and cognitive func-
tions studied in adolescent athletes (26). Our previous 
work has shown a decreasing trend in peripheral IGF-1 
levels following 4 weeks of running; however, these rats 
showed a significant increase in hippocampal neurogen-
esis together with enhanced hippocampal-dependent spa-
tial learning and memory following 2 weeks or 4 weeks of 
running (49,50). Taken together, our data may suggest that 
a constantly elevated level of neurotrophin is not always 
required for enhanced hippocampal neurogenesis and/or 
synaptic plasticity following prolonged physical exercise.
We hypothesized that over a long time when animals 
have chronic exercise, other types of events take place, 
which would result in positive influence on the brain. 
These changes may result in a more long-lasting benefi-
cial effect that is independent of changes in neurotrophin 
levels at later time points of physical exercise. Treadmill 
exercise could enhance brain levels of tropomyosin-
 related kinase B (TrkB, BDNF receptor) and synaptic 
protein in association with enhanced memory in mice 
(18). The observed beneficial effects of continuous run-
ning on our CORT-treated rats may be due to upregulated 
receptor levels of neurotrophin factors, which may in turn 
enhance receptor-triggered downstream signaling even in 
presence of low concentrations of neurotrophins.
Long-Term Physical Exercise as Preventative Measure 
for Stress-Related Mood Disorders
Physical exercise is an effective therapeutic interven-
tion for depressed patients (4,8,13). Marlatt et al. (27) 
Figure 7. Continuous running prevents depression via enhancing hippocampal neurogenesis and levels of synaptic proteins. (A) The 
vehicle-treated nonrunner rats served as basal level for comparison. (B) Under severe conditions with 50 mg/kg CORT treatment, 
concurrent running is unable to reduce depression-like phenotype and restore both hippocampal neurogenesis and synaptic plastic-
ity. (C) Prior running cannot ameliorate CORT-induced increase in depression-like phenotype, which may be linked to decrease in 
hippocampal neurogenesis. (D) Continuous running prevents depressive behavior; this beneficial effect may be mediated by rescued 
hippocampal neurogenesis and enhanced synaptic plasticity.
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have shown that the neurogenic response to exercise in 
mice is much stronger than that to antidepressant treat-
ment with fluoxetine or duloxetine. Regular physical 
exercise potentially serves as the most effective nonphar-
macological tool to enhance brain health. Maintaining an 
active lifestyle will be a preventative measure to reduce 
risk of stress-related disorders or enhance the resilience 
of our body to cope with stress responses in daily life. 
Taken together, our results suggest that lifelong physical 
exercise might be a useful practice for preventing stress-
related mood disorders via maintaining hippocampal 
neurogenesis and synaptic plasticity (Fig. 7).
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